ERAS
Price
$2.08
Change
+$0.27 (+14.92%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
513.44M
40 days until earnings call
RCKT
Price
$3.26
Change
+$0.07 (+2.19%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
344.21M
40 days until earnings call
Interact to see
Advertisement

ERAS vs RCKT

Header iconERAS vs RCKT Comparison
Open Charts ERAS vs RCKTBanner chart's image
Erasca
Price$2.08
Change+$0.27 (+14.92%)
Volume$222.38K
Capitalization513.44M
Rocket Pharmaceuticals
Price$3.26
Change+$0.07 (+2.19%)
Volume$13.14K
Capitalization344.21M
ERAS vs RCKT Comparison Chart in %
Loading...
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERAS vs. RCKT commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERAS is a StrongBuy and RCKT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ERAS: $2.08 vs. RCKT: $3.26)
Brand notoriety: ERAS and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ERAS: 168% vs. RCKT: 29%
Market capitalization -- ERAS: $513.44M vs. RCKT: $344.21M
ERAS [@Biotechnology] is valued at $513.44M. RCKT’s [@Biotechnology] market capitalization is $344.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERAS’s FA Score shows that 1 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • ERAS’s FA Score: 1 green, 4 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, ERAS is a better buy in the long-term than RCKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERAS’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 3 bullish TA indicator(s).

  • ERAS’s TA Score: 4 bullish, 4 bearish.
  • RCKT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ERAS is a better buy in the short-term than RCKT.

Price Growth

ERAS (@Biotechnology) experienced а +13.04% price change this week, while RCKT (@Biotechnology) price change was +6.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

ERAS is expected to report earnings on Nov 05, 2025.

RCKT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ERAS($513M) has a higher market cap than RCKT($344M). ERAS YTD gains are higher at: -27.888 vs. RCKT (-74.065). ERAS has higher annual earnings (EBITDA): -135.93M vs. RCKT (-245.09M). ERAS has more cash in the bank: 301M vs. RCKT (271M). RCKT has less debt than ERAS: RCKT (25.2M) vs ERAS (49.4M). ERAS (0) and RCKT (0) have equivalent revenues.
ERASRCKTERAS / RCKT
Capitalization513M344M149%
EBITDA-135.93M-245.09M55%
Gain YTD-27.888-74.06538%
P/E RatioN/AN/A-
Revenue00-
Total Cash301M271M111%
Total Debt49.4M25.2M196%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ERASRCKT
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ERAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYCCF365.25N/A
N/A
Keyence Corp.
BTRYF0.50N/A
N/A
WARATAH MINERALS LTD.
NGKSY18.02N/A
N/A
NITERRA CO LTD.
GUER1.26N/A
N/A
Guerrilla RF, Inc.
TRUBF4.82N/A
N/A
TRUECALLER AB

ERAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ERAS has been loosely correlated with XNCR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ERAS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERAS
1D Price
Change %
ERAS100%
-5.24%
XNCR - ERAS
55%
Loosely correlated
-1.34%
OCUL - ERAS
54%
Loosely correlated
-2.55%
RVMD - ERAS
50%
Loosely correlated
-2.37%
BEAM - ERAS
50%
Loosely correlated
-2.12%
IRON - ERAS
49%
Loosely correlated
+0.18%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with SVRA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+2.19%
SVRA - RCKT
60%
Loosely correlated
+1.30%
PRTA - RCKT
51%
Loosely correlated
+0.48%
TECH - RCKT
42%
Loosely correlated
+2.73%
RGNX - RCKT
41%
Loosely correlated
+3.10%
ERAS - RCKT
40%
Loosely correlated
+14.92%
More